• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 变异株在 TMPRSS2 缺陷细胞中繁殖时,会在 S1/S2 切割位点发生突变。

SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.

机构信息

Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.

Shionogi & Co., Ltd., Osaka, Japan.

出版信息

PLoS Pathog. 2021 Jan 21;17(1):e1009233. doi: 10.1371/journal.ppat.1009233. eCollection 2021 Jan.

DOI:10.1371/journal.ppat.1009233
PMID:33476327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7853460/
Abstract

The spike (S) protein of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) binds to a host cell receptor which facilitates viral entry. A polybasic motif detected at the cleavage site of the S protein has been shown to broaden the cell tropism and transmissibility of the virus. Here we examine the properties of SARS-CoV-2 variants with mutations at the S protein cleavage site that undergo inefficient proteolytic cleavage. Virus variants with S gene mutations generated smaller plaques and exhibited a more limited range of cell tropism compared to the wild-type strain. These alterations were shown to result from their inability to utilize the entry pathway involving direct fusion mediated by the host type II transmembrane serine protease, TMPRSS2. Notably, viruses with S gene mutations emerged rapidly and became the dominant SARS-CoV-2 variants in TMPRSS2-deficient cells including Vero cells. Our study demonstrated that the S protein polybasic cleavage motif is a critical factor underlying SARS-CoV-2 entry and cell tropism. As such, researchers should be alert to the possibility of de novo S gene mutations emerging in tissue-culture propagated virus strains.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的刺突(S)蛋白与宿主细胞受体结合,从而促进病毒进入。已发现 S 蛋白裂解位点的多碱性基序可拓宽病毒的细胞嗜性和传染性。在此,我们研究了 S 蛋白裂解位点发生突变从而导致蛋白切割效率降低的 SARS-CoV-2 变异株的特性。与野生型毒株相比,具有 S 基因突变的病毒变异株形成的蚀斑更小,且细胞嗜性范围更有限。这些改变是由于它们无法利用涉及宿主 II 型跨膜丝氨酸蛋白酶(TMPRSS2)直接介导融合的进入途径所致。值得注意的是,具有 S 基因突变的病毒迅速出现并成为包括 Vero 细胞在内的 TMPRSS2 缺陷细胞中主要的 SARS-CoV-2 变异株。本研究表明,S 蛋白多碱性裂解基序是 SARS-CoV-2 进入和细胞嗜性的关键因素。因此,研究人员应该警惕在组织培养传代的病毒株中出现新的 S 基因突变的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9014/7853460/72950641116d/ppat.1009233.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9014/7853460/c2ad4752a62f/ppat.1009233.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9014/7853460/2aa712e98fc1/ppat.1009233.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9014/7853460/9ad077c75aed/ppat.1009233.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9014/7853460/9caa7965294a/ppat.1009233.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9014/7853460/72950641116d/ppat.1009233.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9014/7853460/c2ad4752a62f/ppat.1009233.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9014/7853460/2aa712e98fc1/ppat.1009233.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9014/7853460/9ad077c75aed/ppat.1009233.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9014/7853460/9caa7965294a/ppat.1009233.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9014/7853460/72950641116d/ppat.1009233.g005.jpg

相似文献

1
SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.SARS-CoV-2 变异株在 TMPRSS2 缺陷细胞中繁殖时,会在 S1/S2 切割位点发生突变。
PLoS Pathog. 2021 Jan 21;17(1):e1009233. doi: 10.1371/journal.ppat.1009233. eCollection 2021 Jan.
2
SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.SARS-CoV-2 携带 S1/S2 裂解位点突变表现出毒力减弱,并赋予保护性免疫。
mBio. 2021 Aug 31;12(4):e0141521. doi: 10.1128/mBio.01415-21. Epub 2021 Aug 24.
3
Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage.天然和重组 SARS-CoV-2 分离株通过更有效地结合硫酸乙酰肝素和减少 S1/S2 裂解而迅速进化为更高的感染力。
J Virol. 2021 Oct 13;95(21):e0135721. doi: 10.1128/JVI.01357-21. Epub 2021 Aug 18.
4
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.SARS-CoV-2 迅速适应可用的细胞蛋白酶。
J Virol. 2022 Mar 9;96(5):e0218621. doi: 10.1128/jvi.02186-21. Epub 2022 Jan 12.
5
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.SARS-CoV-2 刺突蛋白中的弗林裂解位点是在雪貂中传播所必需的。
Nat Microbiol. 2021 Jul;6(7):899-909. doi: 10.1038/s41564-021-00908-w. Epub 2021 Apr 27.
6
Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein.SARS-CoV-2 刺突蛋白 S1/S2 位点多态性的功能分析。
PLoS One. 2022 Mar 25;17(3):e0265453. doi: 10.1371/journal.pone.0265453. eCollection 2022.
7
Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage.通过弗林蛋白酶介导的高效刺突裂解,适应vero 细胞的 SARS-CoV-2 毒株显示出增强的病毒生长。
Microbiol Spectr. 2024 Apr 2;12(4):e0285923. doi: 10.1128/spectrum.02859-23. Epub 2024 Feb 28.
8
Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.SARS-CoV-2 刺突突变对其被 TMPRSS2 和替代 TMPRSS13 蛋白酶激活的影响。
mBio. 2022 Aug 30;13(4):e0137622. doi: 10.1128/mbio.01376-22. Epub 2022 Aug 1.
9
Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein.中东呼吸综合征冠状病毒刺突蛋白潜在裂解位点的功能分析。
Sci Rep. 2018 Nov 9;8(1):16597. doi: 10.1038/s41598-018-34859-w.
10
Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.鉴定严重急性呼吸综合征冠状病毒 2 的刺突蛋白中的常见缺失。
J Virol. 2020 Aug 17;94(17). doi: 10.1128/JVI.00790-20.

引用本文的文献

1
The recurrent Spike A222V mutation in SARS-CoV-2 enhances replication in primary deer lung cells.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)中反复出现的刺突蛋白A222V突变增强了在原代鹿肺细胞中的复制。
Virus Evol. 2025 Aug 5;11(1):veaf059. doi: 10.1093/ve/veaf059. eCollection 2025.
2
Long-Circulating Nanobody Confers Durable Prophylaxis against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection.长效循环纳米抗体赋予对严重急性呼吸综合征冠状病毒2奥密克戎感染的持久预防作用。
Adv Nanobiomed Res. 2025 Aug;5(8). doi: 10.1002/anbr.202400214. Epub 2025 Jun 27.
3
Multitarget-based screening from phytoactive compounds of fighting toward severe acute respiratory syndrome coronavirus-2.

本文引用的文献

1
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion.SARS-CoV-2 刺突蛋白的受体结合和引发膜融合。
Nature. 2020 Dec;588(7837):327-330. doi: 10.1038/s41586-020-2772-0. Epub 2020 Sep 17.
2
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.SARS-CoV-2 和 SARS-CoV 的比较嗜性、复制动力学和细胞损伤特征分析及其对 COVID-19 临床表现、传染性和实验室研究的影响:一项观察性研究。
Lancet Microbe. 2020 May;1(1):e14-e23. doi: 10.1016/S2666-5247(20)30004-5. Epub 2020 Apr 21.
3
基于多靶点从抗严重急性呼吸综合征冠状病毒2的植物活性化合物中进行筛选
Tzu Chi Med J. 2025 Apr 4;37(3):275-284. doi: 10.4103/tcmj.tcmj_226_24. eCollection 2025 Jul-Sep.
4
Current status and future prospects of toxicity assessment using organoids.使用类器官进行毒性评估的现状与未来展望。
Toxicol Res. 2025 Jun 13;41(4):325-333. doi: 10.1007/s43188-025-00298-9. eCollection 2025 Jul.
5
Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的长期连续传代揭示了趋同进化的特征。
J Virol. 2025 Jul 22;99(7):e0036325. doi: 10.1128/jvi.00363-25. Epub 2025 Jun 9.
6
Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入机制的受体结合:来自原始毒株和新出现变体的见解
Viruses. 2025 May 10;17(5):691. doi: 10.3390/v17050691.
7
Structural basis of TMPRSS11D specificity and autocleavage activation.TMPRSS11D特异性和自切割激活的结构基础。
Nat Commun. 2025 May 10;16(1):4351. doi: 10.1038/s41467-025-59677-3.
8
No Evidence of SARS-CoV-2 Infection in Urban Wildlife of Hokkaido, Japan.日本北海道城市野生动物中未发现感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的证据。
Transbound Emerg Dis. 2024 Aug 13;2024:1204825. doi: 10.1155/2024/1204825. eCollection 2024.
9
Organoids in virology.病毒学中的类器官
Npj Viruses. 2024 Feb 7;2(1):5. doi: 10.1038/s44298-024-00017-5.
10
SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)生物克隆在基因上是异质的,并且包含进化枝不一致的残基。
J Virol. 2025 May 20;99(5):e0225024. doi: 10.1128/jvi.02250-24. Epub 2025 Apr 24.
SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.
利用急性感染住院 COVID-19 患者的血清检测 SARS-CoV-2 的生长、弗林裂解位点适应性和中和作用。
J Gen Virol. 2020 Nov;101(11):1156-1169. doi: 10.1099/jgv.0.001481. Epub 2020 Aug 21.
4
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein.对 SARS-CoV-2 的转录组和蛋白质组进行了特征描述,发现刺突糖蛋白上的弗林样裂解位点发生了细胞传代诱导的框内缺失。
Genome Med. 2020 Jul 28;12(1):68. doi: 10.1186/s13073-020-00763-0.
5
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.TMPRSS2 和 furin 均是 SARS-CoV-2 在人呼吸道细胞中蛋白水解激活所必需的。
Life Sci Alliance. 2020 Jul 23;3(9). doi: 10.26508/lsa.202000786. Print 2020 Sep.
6
Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.鉴定严重急性呼吸综合征冠状病毒 2 的刺突蛋白中的常见缺失。
J Virol. 2020 Aug 17;94(17). doi: 10.1128/JVI.00790-20.
7
SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.严重急性呼吸综合征冠状病毒-2 在 Vero E6 细胞中的复制:复制动力学、快速适应和细胞病变。
J Gen Virol. 2020 Sep;101(9):925-940. doi: 10.1099/jgv.0.001453.
8
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.对 SARS-CoV-2 基因组、结构、进化、发病机制和治疗方法的深入了解:结构基因组学方法。
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165878. doi: 10.1016/j.bbadis.2020.165878. Epub 2020 Jun 13.
9
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner.抗凝剂萘莫司他在细胞融合检测系统中能强力抑制 SARS-CoV-2 S 蛋白介导的融合,并以细胞类型依赖的方式在体外抑制病毒感染。
Viruses. 2020 Jun 10;12(6):629. doi: 10.3390/v12060629.
10
Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的蛋白水解切割及新型S1/S2位点的作用
iScience. 2020 Jun 26;23(6):101212. doi: 10.1016/j.isci.2020.101212. Epub 2020 May 28.